Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
Healthy Volunteers
NCT06722391

Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism

Led by University of Texas, El Paso · Updated on 2024-12-09

80

Participants Needed

1

Research Sites

367 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance training combined with NMES (RT +NMES), or resistance training (RT) group (n=20 per group), followed by collection of post-intervention data. The control group will receive electrical stimulation up to sensory level, the NMES group will receive stimulation up to tolerable intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to tolerable intensity during resistance training, and the RT group will only receive exercise training. Control and NMES group will self administer stimulation at home. Pre-and post-intervention data includes measurements for body composition, resting metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.

CONDITIONS

Official Title

Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Overweight or obese with a Body Mass Index (BMI) of 25 or higher
  • Sedentary lifestyle with a physical activity level less than 1.4
  • Engaging in less than 150 minutes per week of structured exercise
Not Eligible

You will not qualify if you...

  • Use of anti-hypertensive, lipid-lowering, or insulin-sensitizing medications
  • Excessive alcohol use, drug abuse, or smoking
  • Pregnant women
  • Unwillingness to adhere to the study intervention

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Texas at El Paso

El Paso, Texas, United States, 79968

Actively Recruiting

Loading map...

Research Team

S

Sudip Bajpeyi, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here